Marshall Wace’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-29,030
| Closed | -$170K | – | 3181 |
|
|
2022
Q4 | $170K | Buy |
+29,030
| New | +$170K | ﹤0.01% | 2128 |
|
|
2022
Q3 | – | Sell |
-89,146
| Closed | -$374K | – | 3563 |
|
|
2022
Q2 | $374K | Buy |
+89,146
| New | +$374K | ﹤0.01% | 2261 |
|
|
2022
Q1 | – | Sell |
-45,383
| Closed | -$143K | – | 3894 |
|
|
2021
Q4 | $143K | Sell |
45,383
-29,570
| -39% | -$93.2K | ﹤0.01% | 2591 |
|
|
2021
Q3 | $245K | Buy |
74,953
+54,498
| +266% | +$178K | ﹤0.01% | 2144 |
|
|
2021
Q2 | $86K | Sell |
20,455
-32,226
| -61% | -$135K | ﹤0.01% | 2022 |
|
|
2021
Q1 | $263K | Buy |
52,681
+33,216
| +171% | +$166K | ﹤0.01% | 1850 |
|
|
2020
Q4 | $246K | Buy |
+19,465
| New | +$246K | ﹤0.01% | 1565 |
|
|
2019
Q4 | – | Sell |
-3,894
| Closed | -$23K | – | 2121 |
|
|
2019
Q3 | $23K | Sell |
3,894
-98,003
| -96% | -$579K | ﹤0.01% | 1546 |
|
|
2019
Q2 | $1.22M | Buy |
+101,897
| New | +$1.22M | 0.01% | 859 |
|
|
2014
Q2 | – | Sell |
-60,000
| Closed | -$807K | – | 1107 |
|
|
2014
Q1 | $807K | Buy |
+60,000
| New | +$807K | 0.01% | 518 |
|